[go: up one dir, main page]

MX9200570A - Potenciacion del efecto antirreactivo-antiasmaticode los diureticos de asa inhalados por los farmacos anti-inflamatorios no esteroidales inhalados. - Google Patents

Potenciacion del efecto antirreactivo-antiasmaticode los diureticos de asa inhalados por los farmacos anti-inflamatorios no esteroidales inhalados.

Info

Publication number
MX9200570A
MX9200570A MX9200570A MX9200570A MX9200570A MX 9200570 A MX9200570 A MX 9200570A MX 9200570 A MX9200570 A MX 9200570A MX 9200570 A MX9200570 A MX 9200570A MX 9200570 A MX9200570 A MX 9200570A
Authority
MX
Mexico
Prior art keywords
inhaled
reactive
diuretics
inflammatory
pharmaces
Prior art date
Application number
MX9200570A
Other languages
English (en)
Inventor
Sebastiano Bianco
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of MX9200570A publication Critical patent/MX9200570A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El efecto antirreactivo-antiasmático de los diuréticos de asa inhalados se potencia por el uso de una combinación de un diurético de asa y un fármaco anti-inflamatorio no esteroidal como un inhalante para combatir el asma. Se prefiere el uso de un inhibidor de la ciclooxiganasa como el fármaco anti-inflamatorio no esteroidal, y es particularmente preferido el uso de furosemida como el diurético de asa. Es especialmente ventajosos el uso de piretanida como el diurético de asa. Y particularmente preferido el uso de ácido acetilsalicílico como el farmacoanti-inflamatorio no esteroidal.
MX9200570A 1991-02-09 1992-02-10 Potenciacion del efecto antirreactivo-antiasmaticode los diureticos de asa inhalados por los farmacos anti-inflamatorios no esteroidales inhalados. MX9200570A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91101817 1991-02-09

Publications (1)

Publication Number Publication Date
MX9200570A true MX9200570A (es) 1994-07-29

Family

ID=8206392

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200570A MX9200570A (es) 1991-02-09 1992-02-10 Potenciacion del efecto antirreactivo-antiasmaticode los diureticos de asa inhalados por los farmacos anti-inflamatorios no esteroidales inhalados.

Country Status (15)

Country Link
US (2) US5366967A (es)
EP (1) EP0499142A3 (es)
JP (1) JPH0680587A (es)
KR (1) KR920016093A (es)
AU (1) AU652798B2 (es)
BR (1) BR9200430A (es)
CA (1) CA2060954A1 (es)
CS (1) CS35392A3 (es)
HU (1) HU209609B (es)
IE (1) IE920426A1 (es)
IL (1) IL100897A0 (es)
MX (1) MX9200570A (es)
NO (1) NO920503L (es)
NZ (1) NZ241541A (es)
ZA (1) ZA92891B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499143B1 (en) * 1991-02-09 1999-05-06 B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. Anti-reactive anti-asthmatic activity of acetylsalicylic acid by inhalation
BR9604976A (pt) 1995-04-14 1998-06-09 Glaxo Wellcome Inc Inalador de dose medida sistema inalador de dose medida e uso do mesmo
EP1908488A3 (en) * 1995-04-14 2008-04-16 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
DE69631476T2 (de) * 1995-04-14 2005-01-13 Smithkline Beecham Corp. Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat
WO1996032151A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for fluticasone propionate
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
US7028990B2 (en) * 2001-05-11 2006-04-18 Ray Robert Shorey Temporary rooftop and stairway safety rail system
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US10149823B2 (en) 2013-04-30 2018-12-11 Otitopic Inc. Dry powder formulations and methods of use
DK3107548T3 (da) 2014-02-20 2022-07-18 Otitopic Inc Tørpulverformuleringer til inhalation
US10758537B2 (en) * 2015-09-30 2020-09-01 Rutgers, The State University Of New Jersey Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
DE4010536A1 (de) * 1990-04-02 1991-10-10 Boehringer Mannheim Gmbh Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure

Also Published As

Publication number Publication date
US5366967A (en) 1994-11-22
AU652798B2 (en) 1994-09-08
EP0499142A3 (en) 1993-05-05
NO920503D0 (no) 1992-02-07
AU1077092A (en) 1992-08-13
BR9200430A (pt) 1992-10-13
HUT60438A (en) 1992-09-28
CS35392A3 (en) 1992-08-12
IE920426A1 (en) 1992-08-12
EP0499142A2 (en) 1992-08-19
KR920016093A (ko) 1992-09-24
HU209609B (en) 1994-09-28
HU9200390D0 (en) 1992-04-28
ZA92891B (en) 1992-12-30
NO920503L (no) 1992-08-10
CA2060954A1 (en) 1992-08-10
US5750559A (en) 1998-05-12
JPH0680587A (ja) 1994-03-22
NZ241541A (en) 1996-05-28
IL100897A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
MX9200570A (es) Potenciacion del efecto antirreactivo-antiasmaticode los diureticos de asa inhalados por los farmacos anti-inflamatorios no esteroidales inhalados.
BR9200429A (pt) Aplicacao de medicamento anti-inflamatorio nao esteroide e o dito medicamento
ES2061453T3 (es) Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.
MX9400028A (es) Articulo absorbente que tiene alas laterales opcionales.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2145922T3 (es) Compuestos espiro-azabiciclicos utiles en terapia.
ES469005A1 (es) Un procedimiento para la preparacion de nuevos derivados de somatostatina
ES2143093T3 (es) Articulo absorbente para aprendizaje de la utilizacion del inodoro, que crea un cambio de temperatura.
IT1254517B (it) 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
MX9300376A (es) Buje de guia para una columna ajustable longitudinalmente para sillas, mesas o similares.
AR218733A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-(2,3-di(n-alquiloxi o n-alqueniloxi c12-c10)-propil)-4-aminometil-4-fenil-piperidina,y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos
ES2131830T3 (es) Benzamidinas sustituidas, su preparacion y uso como medicamentos.
ES2135046T3 (es) 2-isoxazolinas e isoxazoles 3,5-disustituidos y 3,4,5-trisustituidos, procedimiento para su preparacion y su empleo como medicamentos.
MX9307974A (es) Nuevos derivados de acido hidroxiiminoalquilindolcarboxilico, su obtencion y uso.
ECSP034806A (es) Un producto absorbente con ajuste mejorado
PA8469101A1 (es) Ligandos azabiciclicos de receptores 5ht1
AR033160A1 (es) Producto absorbente
ES2069921T3 (es) Antagonistas del nmda.
ES488311A0 (es) Un procedimiento para la preparacion de pirimido-2-benzace- pinas
ES2098388T3 (es) Activador de biocida.
ES2155537T3 (es) Imidas/amidas inmunoterapicas y su uso para reducir los niveles de tnf-alfa.
ES2097926T5 (es) Uso de derivados de los acidos 1,3,5-triazin-2,4,6-tris-alquilaminocarboxilicos como agentes biocidas.
BR0109874A (pt) bocal para um inalador de particulados
ES2162678T3 (es) Nuevos derivados diarilmetilideno furanicos, sus procedimientos de preparacion y sus utilizaciones en terapeutica.
ES2026832T1 (es) Granada de uso multiple.